HCVERSO2: A Phase Iii Study of Faldaprevir (Fdv) plus Deleobuvir (Dbv) and Ribavirin (Rbv) for Chronic Hcv Genotype (Gt)-1B Infection in Treatment-Naive Patients Including Those Ineligible for Pegylated Interferon (Pegifn)
65Th Annual Meeting of the American-Association-For-The-Study-Of-Liver-Diseases, Date: NOV 07-11, 2014, Location: Boston, MA, Sponsors: Amer Assoc Study Liver Dis
